Checkout
Precision Pot Takes Aim at Unpredictable Highs
- Columbia Care’s Forage program tries to customize experience
- Startups also seek to tailor cannabis for users’ genetics
Source: Columbia Care
This article is for subscribers only.
Cannabis is often positioned as an alternative to mainstream medicine. To keep up, some companies are now trying to fine-tune their offerings to remove the unpredictability long associated with marijuana.
From an electronic pot-recommendation program launched last month by Columbia Care Inc. to DNA analysis by startups such as Endocanna Health Inc., the industry aims to create products akin to personalized or precision medicine, optimized based on genetics, lifestyle or even what kind of experience users want to have. Algorithms that can do so are seen as a holy grail for the cannabis industry, quelling the fears of first-timers and satisfying connoisseurs alike.